The CTN and COVID-19

During the pandemic, it is more important than ever that we work together to flatten the curve. At the CTN, we are proud to be a conduit for the rapid implementation of national co-ordinated COVID-19 trials. Our team of experts are mobilized to help researchers turn a good idea into great research.

About the CTN

The CTN is a collaborative network committed to generating knowledge on the prevention, treatment, and management of HIV, hepatitis C, and other sexually transmitted and blood-borne infections (STBBIs) through the conduct of scientifically sound clinical trials, research, and other interventions.

Led by National Director Dr. Aslam Anis, with National Co-Directors Drs. Sharon Walmsley and Marina Klein, the CTN is dedicated to engaging with the community, maximizing the impact of research, and ultimately improving the health of Canadians.

Find A Study

The CTN supports clinical trials of the highest scientific standards. Each trial has been approved by the Network’s Community Advisory Committee and Scientific Review Committee, or other national peer-review panels.

Knowledge Center

The CTN is committed to maximizing the impact of research to improve the health of Canadians by applying knowledge gained through research at home and abroad into applications and practice.

    HIV & Aging

    Aging is a complex and poorly understood process. The interaction between HIV and aging increases this complexity and presents a unique set of challenges.

    Learn More

    STBBIs

    Response to the HIV epidemic now includes elimination of other sexually transmitted and blood-borne infections (STBBIs), such as syphilis and gonorrhea.

    Learn More

    Cure

    Research in targeted immunotherapies, vaccines, and emerging areas of research in treatment, immune system support, and cure.

    Learn More

    Guidelines

    CTN-supported guidelines for patient care help to support the use of best practices by clinicians, community members, and policy makers.

    Learn More
News

July 30, 2020

Engage-COVID-19

New funding for CTN 300-2 will allow the study team to document COVID-19 infection, immunity, and related determinants in gay, bisexual, and other men who have sex with men

Learn More
News

July 29, 2020

OPAL-COVID-19 Study

Dr. Bertrand Lebouché joins the creators of the health app Opal to repurpose it for COVID-19 patients recovering from home

Learn More

Our Publications

Through CTN-supported studies, our Investigators have produced hundreds of peer-reviewed publications in a wide range of HIV- and STBBI-related areas.